AI is already helping to understand individual health patterns and create more targeted nutrition solutions, says Amit Srivastava, Founder, Nutrify Today
We are witnessing a shift from a fragmented market of “traditional supplements” to a highly structured, tech-enabled nutraceutical industry. What are the key economic drivers currently professionalizing this space globally?
Nutraceuticals are not just “wellness products” anymore; they are part of a larger preventive healthcare economy today. The nutraceutical industry is rapidly changing with consumers seeking evidence-based, personalized, and traceable health solutions.
The sector is becoming more structured, scalable and investment driven, with innovation accelerating due to advances in AI, regulatory technology and connected supply chains. At the same time, the global shift towards preventive healthcare is raising nutraceuticals to the level of a fundamental pillar of future wellness economies.
With the rise of AI-driven health data, how close is the industry to achieving truly personalised “precision nutrition”?
What is exciting about this moment is that precision nutrition is no longer a futuristic idea — it is becoming possible. AI is already helping to understand individual health patterns and create more targeted nutrition solutions, but the real challenge is to build trust through clinical validation and responsible use of data. Now the industry is moving away from “mass wellness” to genuinely personalised health experiences.
Artificial Intelligence is now being used to predict successful formulations and identify ingredient synergies. In what ways is this predictive technology reducing the traditional 2–3 year “idea-to-shelf” timeline in the nutraceutical space?
Today innovation does not have to be trial and error. Predictive AI enables companies to identify promising ingredient synergies, consumer trends and formulation opportunities much earlier, dramatically shortening development times. It’s helping the industry transition from “experiment first” to “predict, validate, and scale faster.”
Given recent global disruptions, how can the integration of digital marketplaces and AI-powered sourcing platforms create a more resilient and ethically transparent global supply chain for raw botanical ingredients?
Global upheavals have increased demand for improved, more transparent supply chains in the nutraceutical industry. AI-powered sourcing platforms and digital markets boost supply chain resilience and efficiency by delivering better risk forecasts, certified suppliers and improved traceability. In addition they are increasing the ethical transparency of ingredient sourcing and sustainability.
The industry is moving away from isolated businesses toward integrated “ecosystems” (connecting R&D, manufacturers and regulators). How has this collaborative model changed the success rate of startups compared to a decade ago?
Over the past 10 years, there has been a huge change: Startups no longer have to innovate in a vacuum. The move to integrated ecosystems has significantly improved how nutraceutical startups innovate and scale.
“Startups can now plug into R&D, manufacturing and regulatory expertise and commercialization networks to validate their products faster and reduce operational and compliance challenges. This kind of collaboration has made innovation more efficient, more scalable and more success-oriented than it was ten years ago.
With the industry’s heavy reliance on natural extracts how are new launches balancing the need for high-potency ingredients with the growing necessity for sustainable, regenerative agriculture and biodiversity protection?
What makes today’s discussion on nutraceuticals particularly interesting is that it is not just about stronger or more potent ingredients. Consumers and brands are asking more in-depth questions about how these botanical extracts are grown, sourced and sustained without damaging ecosystems or biodiversity.
So the industry is moving towards a more balanced approach where high performance nutrition and long term environmental responsibility are evolving in tandem, rather than separately.
With the advent of platforms utilizing millions of data points to predict ingredient synergies, how is AI fundamentally changing the risk profile and success rates of new product development in the nutrition sector?
What is really changing with AI is the product development is becoming much less dependent on educated guesses. AI is helping companies to identify better opportunities sooner, and to reduce costly innovation risks by analyzing millions of data points about ingredient synergies, clinical evidence and consumer preferences. The result is a quicker, smarter, more predictable route to successful product launches.
As demand for specialized ingredients increases what are the primary challenges in maintaining ethical sourcing and biodiversity and how can technology help decouple industry growth from environmental depletion?
The growing demand for specialty ingredients is posing issues in terms of overharvesting, traceability, and biodiversity conservation. Technology especially AI-driven sourcing and digital traceability systems, can improve responsible forecasting of demand and development of more sustainable, transparent supply chains. We are now focused on growing with innovation and in accordance with the ecology.
What specific technical skills are currently most lacking in the nutraceutical workforce—scientific formulation, digital supply chain management, or regulatory compliance?
The industry clearly does not need specialists working in silos anymore. The nutraceutical industry is only exacerbating the shortage of multidisciplinary talent that brings together science, regulatory and digital know-how.
While formulation science still matters, expertise in regulatory compliance, supply chain management using AI and data-driven product development are becoming equally critical. We want people in the industry who can work across connected ecosystems and not in separate functions.
What are some of the most significant hurdles that companies face when entering the nutraceutical industry, aside from product development?
In addition to product development, nutraceutical businesses typically encounter hurdles such as regulatory compliance, supply chain dependability, scientific validation, and consumer trust in a competitive market.
Scaling a firm also requires a robust ecosystem support in manufacturing, technology and commercialization. Today’s success depends as much on strategic collaboration as it does on innovation itself.
